Investor Presentaiton

Acquisition Terms Acquisition consideration Timing Restraints Additional terms LGP has acquired LGP Denmark (including the Denmark Facility) for C$20 million (A$21.4 million¹) payable in cash as follows: C$10 million (A$10.7 million¹) Initial Consideration paid on Completion; and C$10 million (A$10.7 million¹) payable in 12 months pursuant to a retained loan at an imputed interest rate of 12.5% Purchased on a cash-free, debt-free basis with final purchase price adjusted on a dollar-for-dollar basis for all cash on hand at Completion The acquisition Completed on Monday, 21 June 2021 Canopy restrained from producing and exporting from Denmark and selling medicinal cannabis flower into Denmark for a period of 24 months from Completion, and from purchasing medicinal cannabis flower from third parties in Denmark for 12 months from Completion Canopy to provide LGP: a licence to allow LGP to use the four medicinal cannabis cultivars currently produced by the Denmark Facility for a period of 12 months; and transitional IT services 1. CADAUD: 1.07 little green pharma 21

View entire presentation